SSKN

STRATA Skin Sciences Inc

SSKN, USA

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

https://www.strataskinsciences.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SSKN
stock
SSKN

Strata Skin Sciences Holds Annual Stockholder Meeting TipRanks

Read more →
SSKN
stock
SSKN

STRATA Skin Sciences (NASDAQ: SSKN) showcases XTRAC® and TheraclearX® at TeraCILAD Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$7.4

Analyst Picks

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

50.13

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-123.44 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-5.28 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-15.62 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

22.38

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 30.41% of the total shares of STRATA Skin Sciences Inc

1.

22NW, LP

(12.874%)

since

2025/06/30

2.

Nantahala Capital Management, LLC

(9.6836%)

since

2025/06/30

3.

Renaissance Technologies Corp

(2.3502%)

since

2025/06/30

4.

Vanguard Group Inc

(2.029%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(0.7014%)

since

2025/07/31

6.

Geode Capital Management, LLC

(0.4362%)

since

2025/06/30

7.

We Are One Seven, LLC

(0.411%)

since

2025/06/30

8.

Vanguard Institutional Extnd Mkt Idx Tr

(0.3878%)

since

2025/07/31

9.

Tower Research Capital LLC

(0.3534%)

since

2025/06/30

10.

Fidelity Extended Market Index

(0.305%)

since

2025/07/31

11.

Creative Planning Inc

(0.2401%)

since

2025/06/30

12.

UBS Group AG

(0.1753%)

since

2025/06/30

13.

BlackRock Inc

(0.107%)

since

2025/06/30

14.

Fidelity Series Total Market Index

(0.0655%)

since

2025/07/31

15.

Northern Trust Extended Eq Market Idx

(0.0473%)

since

2025/06/30

16.

NT Ext Equity Mkt Idx Fd - L

(0.0473%)

since

2025/06/30

17.

Fidelity Nasdaq Composite Index

(0.0418%)

since

2025/07/31

18.

Vanguard Instl Ttl Stck Mkt Idx Tr

(0.0347%)

since

2024/12/31

19.

Vanguard Instl Ttl Stk Mkt Idx InstlPls

(0.0347%)

since

2025/07/31

20.

NT Ext Equity Mkt Idx Fd - NL

(0.0135%)

since

2025/06/30

21.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0133%)

since

2025/06/30

22.

Spartan Extended Market Index Pool F

(0.0127%)

since

2025/07/31

23.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0113%)

since

2024/12/31

24.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0105%)

since

2025/06/30

25.

Spartan Total Market Index Pool G

(0.0095%)

since

2025/07/31

26.

Mccormack Advisors International

(0.0072%)

since

2025/06/30

27.

Bank of America Corp

(0.0047%)

since

2025/06/30

28.

Financial Perspectives Inc

(0.0024%)

since

2025/06/30

29.

Fidelity Total Market Index

(0.0013%)

since

2025/07/31

30.

State St US Extended Mkt Indx NL Cl C

(0.0005%)

since

2025/08/31

31.

Fidelity U.S. Equity Index Ins Trust

(0.0003%)

since

2025/07/31

32.

SSgA U.S. Total Market Index Strategy

(0.0002%)

since

2025/03/31

33.

Hanson Mcclain Inc

(0.0001%)

since

2025/06/30

34.

NT Quality SCC US Fund - L

(0.0001%)

since

2025/06/30

36.

Citadel Advisors Llc

(0%)

since

2025/06/30

37.

JPMorgan Chase & Co

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.3575

EPS Estimate

-0.24

EPS Difference

-0.1175

Surprise Percent

-48.9583%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(3.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(1)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Low Quality Business(1.5)
Value
Overpriced(2)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.